Session Chair: Dr. Manuela Rodriquez, Visiting Scientist, Broad Institute of Harvard and MIT, USA Co-Chair: Dr. Moshe Szyf, Professor Department of Pharmacology and Therapeutics McGill University Canada

Title: New Findings of Neuro-Oncological Drug Discovery
Dr. Francis Ali-Osman, Margaret Harris and David Silverman Distinguished Professor of Neuro-Oncology Research, Department of Surgery, Duke University School of Medicine, USA

Title: DNA Demethylation and Cancer Metastasis: Therapeutic Implications
Dr. Moshe Szyf, Professor Department of Pharmacology and Therapeutics McGill University Canada

Title: Non-invasive Fluorescent Imaging for Profiling Developmental Neurotoxicity in Transgenic Mice
Dr. Zhuo Lang, Principal Scientist, Institute of Bioengineering and Nanotechnology, Singapore

Title: Known Targets and Chemotypes with New and Unexpected Therapeutic Potential
Dr. Jochen Antel, Solvay Pharmaceuticals Research Laboratories, Germany

Title: Therapeutic Promise Of C-Jun N-Terminal Kinase (Jnk) Inhibitors
Dr. Marie A. Bogoyevitch, Biochemistry and Molecular Biology, University of Western Australia, Australia

Title: Ligand-directed Targeting and Molecular Genetic Imaging in Diseases with an Angiogenesis Component
Dr. Wadih Arap, Stringer Professor of Medicine and Cancer Biology, USA
Dr. Renata Pasqualini, Professor of Medicine and Cancer Biology, University of Texas M.D. Anderson Cancer Center, USA

Title: Combinatorial Effects of Doxorubicin and STI571 on Growth, Differentiation and Apoptosis of CML Cell Line K562
Dr. Malgorzata Czyz, Head of Department of Molecular Biology of Cancer, Medical University of Lodz, Poland